Samuel Blackman

Director at Bonum Therapeutics.

Earliest Form D on file: Apr 2026

Filed Apr 17, 2026

Bonum Therapeutics

Cytokine therapies that switch on only at their target

Biotech, Seattle WA

Named, Director.

$26.9M

sold of $32.3M offered

Network

At Bonum Therapeutics

10 people

John Mulligan
Executive Officer, Director, Promoter, signed as Chief Executive Officer
Diane Hollenbaugh
Executive Officer
Gaurav Aggarwal
Director
John McKearn
Director
Karl Handelsman
Director
Mitchell Mutz
Director

4 more at Bonum Therapeutics